That is a good question. The simple answer is that Vivimind is an over-the-counter nutraceutical memory protection therapy. The company behind Vivimind, OVOS Natural Health Inc. , claims that their new Vivimind product is a newly patented product which is based on a naturally occurring ingredient called homotaurine. Homotaurine is known to bind to beta-amyloid (also known as A-beta) proteins and subsequently reduce the deposition of these A-beta proteins in the Human brain.
This is important because many scientists have come to believe that the gradual build up of a specific toxic protein (the A-beta) is detrimental to the brain. When this protein buildup reaches excessive levels, it can often cause neurons (brain cells) within the brain to malfunction and eventually die. When these neurons are damaged or die, communication or signaling problems occur in the brain that ultimately affect our memory and learning abilities. The death of these brain cells is reflected by a gradual shrinkage of the region from which they are lost: the hippocampus, the region of the brain associated with learning and memory.
When describing the effects of their Vivimind nutraceutical, OVOS makes the following claim:
VIVIMIND is scientifically proven to protect memory function, based on the naturally occurring ingredient, homotaurine, found in seaweed. VIVIMIND:
- Protects the brain structure associated with memory and learning
- Preserves memory
- Sustains brain cell health
- Maintains verbal skills and comprehension ability
- Supports planning and execution skills
When discussing the various test results for their new product, Vivimind, Ovos make the following claims about their success:
Considering its massive potential for an aging population, you can start to imagine why the makers of Vivimind are excited about finally releasing it onto the market; if it is perceived by consumers to be of some preventative value, then its commercial potential could be quite massive as well. Given the financial stakes involed here, obviously the first few months of marketing and sales will be of extreme importance. It will be very interesting to see how well Vivimind catches on with its target market in particular, and the public in general.
In a groundbreaking study performed in Canada and the United States using brain scans (magnetic resonance imaging (MRI)), VIVIMIND was shown to significantly reduce the loss of brain volume in the hippocampus. In fact, VIVIMIND was proven to preserve 68% more brain volume versus placebo (like a sugar pill).Individuals taking VIVIMIND also performed better on memory and thinking tests compared with individuals taking placebo. VIVIMIND was found to improve cognitive performance (verbal skills, memory, comprehension ability, planning and execution skills) by 33% versus placebo.
( source: Ovos Health )